Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antimetabolites”

34 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 34 results

Early research (Phase 1)Study completedNCT02185794
What this trial is testing

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Voxilaprevir in Adults With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 101
Large-scale testing (Phase 3)Study completedNCT01829295
What this trial is testing

Methotrexate and Mycophenolate Mofetil for UVEITIS

Who this might be right for
Uveitis
University of California, San Francisco 216
Very early researchWithdrawnNCT04220892
What this trial is testing

Pilot Study of Pembrolizumab Combined With Pemetrexed or Abemaciclib for High Grade Glioma

Who this might be right for
High Grade Glioma
Jose Carrillo
Large-scale testing (Phase 3)Study completedNCT01091168
What this trial is testing

Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer

Who this might be right for
Breast CancerMetastases
Pierre Fabre Medicament 594
Large-scale testing (Phase 3)Study completedNCT01701401
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination (FDC) With and Without Ribavirin for the Treatment of HCV

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 870
Testing effectiveness (Phase 2)Study completedNCT00593151
What this trial is testing

Study of Safety, Tolerability, and Anti-Viral Effect of Locteron Compared to PEG-Intron in Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C
Biolex Therapeutics, Inc. 32
Testing effectiveness (Phase 2)UnknownNCT01297803
What this trial is testing

Comparison of Two Method Antimetabolites Application on Corneal Function in Trabeculectomy Surgery

Who this might be right for
Glaucoma Patients Scheduled for Trabeculectomy
Shahid Beheshti University of Medical Sciences
Not applicableApproved For MarketingNCT01779518
What this trial is testing

Expanded Access Program of Sofosbuvir With Ribavirin and With or Without Pegylated Interferon in Aggressive Post-transplant Hepatitis C

Who this might be right for
Post-transplant Hepatitis C
Gilead Sciences
Not applicableStudy completedNCT04736472
What this trial is testing

Implementing Pharmacogenetic Testing in Gastrointestinal Cancers

Who this might be right for
Gastrointestinal Cancer
Abramson Cancer Center at Penn Medicine 552
Large-scale testing (Phase 3)Study completedNCT01768286
What this trial is testing

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed-Dose Combination ± Ribavirin in Treatment-Experienced Subjects With Genotype 1 HCV Infection

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 441
Post-approval studies (Phase 4)Study completedNCT01201811
What this trial is testing

Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS)

Who this might be right for
Myelodysplastic Syndromes
Celgene 44
Early research (Phase 1)Study completedNCT00001449
What this trial is testing

A Phase I Study of Weekly Gemcitabine in Combination With Infusional Fluorodeoxyuridine and Oral Calcium Leucovorin in Adult Cancer Patients

Who this might be right for
Neoplasms
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Study completedNCT01397305
What this trial is testing

An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer

Who this might be right for
Rectal Cancer
Isofol Medical AB 24
Testing effectiveness (Phase 2)Study completedNCT00001493
What this trial is testing

Antimetabolite Induction, High-Dose Alkylating Agent Consolidation and Retroviral Transduction of the MDR1 Gene Into Peripheral Blood Progenitor Cells Followed by Intensification Therapy With Sequential Paclitaxel and Doxorubicin for Stage 4 Breast Cancer

Who this might be right for
Breast NeoplasmsNeoplasm Metastasis
National Cancer Institute (NCI) 42
Large-scale testing (Phase 3)Study completedNCT01232920
What this trial is testing

First-line Antimetabolites as Steroid-sparing Treatment Uveitis Pilot Trial

Who this might be right for
Uveitis
University of California, San Francisco 80
Large-scale testing (Phase 3)UnknownNCT01122966
What this trial is testing

The Effect of Bevacizumab on the Trabeculectomy

Who this might be right for
Glaucoma
Samsung Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT04962958
What this trial is testing

Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery

Who this might be right for
CarcinomaCarcinoma, HepatocellularLiver Neoplasms+6 more
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 30
Early research (Phase 1)Study completedNCT00001764
What this trial is testing

Mycophenolate Mofetil to Treat Wegener's Granulomatosis and Related Vascular Inflammatory Conditions

Who this might be right for
VasculitisWegener's Granulomatosis
National Institute of Allergy and Infectious Diseases (NIAID) 50
Large-scale testing (Phase 3)Study completedNCT02996682
What this trial is testing

Efficacy and Safety of Sofosbuvir/Velpatasvir ± Ribavirin for 12 Weeks in Adults With Chronic HCV Infection and Decompensated Cirrhosis

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 102
Large-scale testing (Phase 3)Study completedNCT03828019
What this trial is testing

Adalimumab vs. Conventional Immunosuppression for Uveitis Trial

Who this might be right for
Uveitis
JHSPH Center for Clinical Trials 227
Next Page